Delving into the Latest Updates on Hefei Everlife Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Hemic and Lymphatic Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

NKRF(NF-kappa-B-repressing factor)	1

Primary objective: To evaluate the hematological improvement (HI) rate of MDS patients with low-risk and intermediate-risk-1 IPSS scores treated with CDA-Ⅱ; Secondary objectives: Changes in transfusion requirements, observation of complete remission (CR) and partial remission (PR), duration of hematological improvement (HI), quality of life (QLQ) and safety.

Start Date31 Oct 2014

Sponsor / Collaborator

Hefei Everlife Pharmaceutical Co., Ltd.

CTR20140557

/ RecruitingPhase 4

喜滴克(尿多酸肽注射液)联合化疗治疗晚期乳腺癌、非小细胞肺癌开放、多中心IV 期临床试验

[Translation] An open, multicenter Phase IV clinical trial of Xidic (uropolyacitide injection) combined with chemotherapy for the treatment of advanced breast cancer and non-small cell lung cancer

旨在评价国家I 类抗癌新药喜滴克上市后联合化疗用于治疗晚期乳腺癌、非小细胞肺癌的安全性和临床获益。

[Translation]

The aim is to evaluate the safety and clinical benefits of Xidic, a national Class I anticancer new drug, combined with chemotherapy for the treatment of advanced breast cancer and non-small cell lung cancer after its launch.

Start Date-

Sponsor / Collaborator

Hefei Everlife Pharmaceutical Co., Ltd.

100 Clinical Results associated with Hefei Everlife Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Hefei Everlife Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Hefei Everlife Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Hefei Everlife Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2

1

Login to view more data